Besremi Pen Injection, Solution
Product Images NDC 73536-511

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Besremi Pen (NDC 73536-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaessentia Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Besremi 01)

An instructional diagram of the BESREMi Pen injection device showing its parts. Labels identify the syringe cap, textured collar, dose lines, syringe body, gray stopper, finger flange, and plunger on the syringe. The needle assembly is shown separately with clear needle cap, pink needle shield, and needle.*

FDA Label Image

Figure B (Besremi 02)

An instructional diagram showing the BESREMi Pen carton stored inside a refrigerator compartment. The image includes the BESREMi carton on the left and a refrigerator interior on the right, indicating proper cool storage of the product.*

FDA Label Image

Figure C & D (Besremi 03)

An instructional diagram showing how to adjust the medicine level on a BESREMi Pen syringe for a prescribed dose. It highlights aligning the top outer edge of the gray stopper with the dose line on the syringe, illustrated with examples for a 350 mcg dose. The diagram advises against measuring from the dome at the top of the stopper, using clear labels and arrows to guide proper dose setting.*

FDA Label Image

Figure E (Besremi 04)

An illustration showing the BESREMi Pen injection packaging alongside a detailed diagram of the pen device's internal cartridge and dosing mechanism. The image highlights how the medication cartridge is contained within the pen for subcutaneous injection.*

FDA Label Image

Figure F (Besremi 05)

An illustration labeled Figure F showing the packaging of BESREMi Pen, an injectable solution of ROPEGINTERFERON ALFA-2B. The image highlights the location of the expiration date on the box, indicated as 'EXP: YYYY-MM,' along with a visible barcode and other package details.*

FDA Label Image

Figure G (Besremi 06)

Illustration showing a BESREMi Pen box on a surface next to a timer displaying a countdown labeled 15-30 minutes, likely indicating a preparation or usage time related to the product.*

FDA Label Image

Figure H (Besremi 07)

Instructional illustration labeled as Figure H showing a single square or rectangular pad or patch with the text 'ROUTING' on it, possibly related to the BESREMi Pen injection device or its administration process. The image shows the pad's front view with a blank section above the text.*

FDA Label Image

Figure I (Besremi 08)

An illustration of a sharps disposal container designed for safe disposal of used needles and syringes. The container is rectangular with a white lid and red body, featuring a label on the side for identification.*

FDA Label Image

Figure J (Besremi 09)

An instructional illustration labeled Figure J showing a paper towel dispenser with the paper towel directed toward a sink and a trash can labeled TRASH positioned nearby, suggesting proper disposal of used materials during injection preparation or administration.*

FDA Label Image

Figure K (Besremi 10)

An instructional illustration showing a single-use alcohol prep pad and a small cotton ball placed on top of a beige-colored strip, possibly a bandage or adhesive tape, used in a medical or injection-related context.*

FDA Label Image

Figure L (Besremi 11)

An instructional illustration labeled "Figure L" showing hands removing or handling a protective cover on the top of a vial or cartridge, likely demonstrating part of the preparation process for injection.*

FDA Label Image

Figure M (Besremi 12)

An instructional illustration showing the BESREMi Pen injection packaging with an arrow indicating the opening of the outer carton to reveal the pen device inside a clear plastic tray. The figure is labeled as 'Figure M.'*

FDA Label Image

Figure N (Besremi 13)

An instructional diagram showing a hand removing a prefilled BESREMi Pen injector from its plastic packaging tray. The image highlights the pen syringe with visible label information and a cap at the end opposite the needle assembly.*

FDA Label Image

Figure O (Besremi 14)

An instructional illustration showing a close-up of an eye observing a dose indicator on an injection pen. The pen is marked with dose levels in micrograms up to 900 and features a plunger and black dose cap at the top. This likely relates to the use or dosing of the BESREMi Pen injection device by PharmaEssentia USA.*

FDA Label Image

Figure P (Besremi 15)

An instructional illustration showing a hand peeling off the backing from a medical device, with an arrow pointing to the device after the backing is removed, indicating preparation for use. The figure is labeled 'Figure P.'*

FDA Label Image

Figure Q (Besremi 16)

An instructional illustration showing two hands preparing a syringe. The top hand is holding and rotating a black cap or component, while the bottom hand holds the syringe vertically. The image is labeled 'Figure Q'.*

FDA Label Image

Figure R (Besremi 17)

An instructional illustration showing hands removing a cap from a syringe needle by twisting and pulling upward. The image is labeled as Figure R and demonstrates the step of preparing an injection for the BESREMi Pen injection solution, 500 ug/.5mL or 500 ug/mL.*

FDA Label Image

Figure S (Besremi 18)

An instructional illustration labeled Figure S, depicting a syringe attached to a pen-like injection device, likely demonstrating use or assembly for a subcutaneous injection.*

FDA Label Image

Figure T (Besremi 19)

An anatomical illustration showing recommended subcutaneous injection sites for BESREMi Pen (Ropeginterferon Alfa-2b). Highlighted areas include the abdomen below the navel, the sides of the upper thighs, and around the lower back/hip region.*

FDA Label Image

Figure U (Besremi 20)

An instructional illustration showing a hand cleaning the skin surface with a cotton pad or swab prior to injection, as part of subcutaneous injection preparation for the BESREMi Pen (ROPEGINTERFERON ALFA-2B). The figure is labeled as Figure U.*

FDA Label Image

Figure V (Besremi 21)

Instructional illustration showing the proper technique for using the BESREMi Pen injection device. The image depicts a hand holding the pen and another hand performing an action, likely related to preparing or administering a subcutaneous injection.*

FDA Label Image

Figure W (Besremi 22)

An instructional illustration showing a hand holding a syringe with the other hand removing a needle cap by pulling it straight off. The image indicates proper needle uncapping technique for injection preparation.*

FDA Label Image

Figure X (Besremi 23)

An instructional illustration showing a hand pressing the plunger of a prefilled pen injector syringe, likely demonstrating the procedure to administer a subcutaneous injection. The pen injector appears to be held steady by the other hand.*

FDA Label Image

Figure Y (Besremi 24)

Illustration titled 'Prescription Card' showing a placeholder for a dosage amount in micrograms (mcg) for the BESREMi Pen injection, solution, subcutaneous use by PharmaEssentia USA.*

FDA Label Image

Figure Z (Besremi 25)

An instructional illustration showing how to hold a syringe vertically and push up slowly to adjust medication to the prescribed dose. The syringe is marked with dosage levels, with an example dose of 350 mcg highlighted. A caution note advises users to adjust the medicine level in the syringe to match their prescribed dose rather than relying on the example shown.*

FDA Label Image

Figure Aa (Besremi 26)

An instructional illustration showing a hand pinching the skin, likely demonstrating a subcutaneous injection technique. The figure is labeled 'Figure AA'.*

FDA Label Image

Figure Ab (Besremi 27)

An instructional diagram showing the proper subcutaneous injection technique with a syringe held at a 45-degree angle to the skin. The image demonstrates correct injection angle and hand positioning for administration.*

FDA Label Image

Figure Ac (Besremi 28)

An instructional illustration showing a hand holding a syringe at an angle, poised to inject into the skin subcutaneously. The image demonstrates the correct injection technique for a subcutaneous injection.*

FDA Label Image

Figure Ad (Besremi 29)

An instructional illustration showing the proper technique for using a subcutaneous injection device, with an arrow indicating the direction to insert the needle under the skin.*

FDA Label Image

Figure Ae (Besremi 30)

An instructional illustration showing a person removing the cap from the needle of a prefilled pen device for injection. The diagram depicts hands holding the pen and lifting the cap off, with an arrow indicating the direction of removal.*

FDA Label Image

Figure Af (Besremi 31)

An instructional illustration showing a hand holding a syringe angled downward above a sharps disposal container, demonstrating proper syringe disposal technique by ejecting contents or removing a needle prior to discarding.*

FDA Label Image

Figure Ag (Besremi 32)

An instructional illustration showing a hand using a cotton ball to clean or prepare an area of the skin. The image is labeled as Figure AG.*

FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Label)

Label for BESREMi Pen, containing ropeginterferon alfa-2b, with a strength of 500 mcg/mL in injectable solution form for subcutaneous use. The label includes a dosage scale marking doses from 50 to 500 mcg, a barcode, and packaging information including lot and expiration date fields. Manufactured by PharmaEssentia Corp.*

FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Carton)

Packaging label for BESREMi Pen (ropegnterferon alfa-2b-njft) injection, 500 mcg/mL, a single-dose prefilled syringe for subcutaneous use. The label includes dosage strength, usage warnings, contents such as the syringe and needle, and manufacturer information for PharmaEssentia USA. It also lists inactive ingredients and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.